Skip to main content

Ordering Recommendation

• This is an autoantibody test on two substrates covering different specificities and sensitivities for initial diagnostic assessment and disease monitoring in IgG-variant pemphigus, including pemphigus vulgaris and pemphigus foliaceus, diseases that present with blistering and erosions, affecting skin and mucous membranes.

• Order concurrently with perilesional skin biopsy for direct immunofluorescence for initial diagnosis.

• Use for disease monitoring with semiquantitative antibody level assessments and tracking

• Consider more broad-based panel autoantibody assessment initially and for persisting unexplained or worsening disease activity because antibody detection may evolve over time; panels that include IgG cell surface antibodies are: Epithelial Antibody Screening Panel and Pemphigus Panel.


Methodology

Indirect immunofluorescence - monkey esophagus and human intact skin substrates


Performed

Daily


Reported

2-5 days


New York State Department of Health (NYSDOH) Approval Status

This test is New York State DOH approved.


Information Required to Submit with Order

Completed Immunodermatology Laboratory requisition form and copies of both sides of insurance cards or completed billing information


CPT Code(s)

88346; 88350 (86256 x 1-2 possible)
 

SPECIMEN REQUIREMENTS

Collect Blood

Plain red top tube or serum separator tube.  


Specimen Preparation

2 mL serum separated from blood into serum vial provided in kit (Minimum needed: 0.5 mL) 


Storage/Transport Temperature

Room temperature  


Conditions with Disclaimer for Potentially Anomalous Results

Hemolyzed or lipemic serum specimens, whole blood  


Stability

Ambient: 7 days
Refrigerated: 14 days
Frozen: Indefinitely